Risk factors for mortality of patients with ceftriaxone resistant E. coli bacteremia receiving carbapenem versus beta lactam/beta lactamase inhibitor therapy

OBJECTIVE: Extended spectrum β-lactamases (ESBL) producing Enterobacteriaceae predominantly E. coli and K. pneumoniae bacteremia have limited treatment options and high mortality. The objective was to determine the risk factors for in-hospital mortality particularly treatment with carbapenem versus...

Descripción completa

Detalles Bibliográficos
Autores principales: Nasir, Nosheen, Ahmed, Sara, Razi, Samrah, Awan, Safia, Mahmood, Syed Faisal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6757396/
https://www.ncbi.nlm.nih.gov/pubmed/31547853
http://dx.doi.org/10.1186/s13104-019-4648-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6757396/
https://www.ncbi.nlm.nih.gov/pubmed/31547853
http://dx.doi.org/10.1186/s13104-019-4648-7

Ejemplares similares